BMS 247550 to Treat Kidney Cancer

NCT00030992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

NIH

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: BMS-247550
DRUG: Ranitidine
DRUG: Diphenhydramine

Sponsor

National Cancer Institute (NCI)